metformin has been researched along with abt-199 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreeff, M; Bornmann, W; Duque, JE; Enciso, L; Jaramillo, D; Konopleva, M; Krystal, G; Lee, JT; Lopez, C; Morales, L; Pan, R; Samudio, I; Suarez, M; Velez, J | 1 |
| Chen, J; Du, J; Hua, L; Huang, K; Jiang, X; Lai, J; Li, Y; Liu, F; Yang, N; Yu, Z; Zeng, H | 1 |
2 other study(ies) available for metformin and abt-199
| Article | Year |
|---|---|
Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transport.
Topics: Apoptosis; Biguanides; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Electron Transport; Humans; Metformin; Mitochondria; Nitrophenols; Phenformin; Piperazines; Rotenone; Sulfonamides; U937 Cells | 2016 |
Metformin sensitizes AML cells to venetoclax through endoplasmic reticulum stress-CHOP pathway.
Topics: Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Endoplasmic Reticulum Stress; Humans; Leukemia, Myeloid, Acute; Metformin; Neoplasm Recurrence, Local; Proto-Oncogene Proteins c-bcl-2 | 2023 |